Inositec
Inositec is a biotech company that was founded in 2015 as a spin-off of ETH Zurich. They specialize in developing a treatment for soft tissue calcification disorders using their proprietary Inositune platform of inositol phosphate (IP6) analogs. Their main focus is on addressing vascular and renal calcification disorders, including orphan indications....
N/A
Technology
N/A
Founded
N/A
Employees
Advanced and Next Generation Therapies (Various)
Industry
Visual (Placeholder)
Profile Information
Name
Inositec
Industry
Advanced and Next Generation Therapies (Various)
Technology
N/A
Location
N/A
Founded
N/A
Employees
N/A
Category
Companies